JESSIE ILES: Open Payments
NPI 1619337367 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 20 payments from 9 companies in 2025. Trend: 2023 $160 · 2024 $860 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $394 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Viatris Specialty LLC | 1 | $122 |
| Sage Therapeutics, LLC | 1 | $100 |
| Edwards Lifesciences Corporation | 1 | $96 |
| Novo Nordisk Inc | 1 | $87 |
| Neurelis, Inc. | 1 | $59 |
| KYOWA KIRIN, INC. | 1 | $52 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: VRAYLAR, TARPEYO, YUPELRI, SAPIEN 3 Ultra RESILIA, Wegovy, VALTOCO.
Industry payments across LA — which companies pay providers there.
